About Bridging integrator 2
Bridging integrator 2 (BIN2) is a protein
from Homo sapiens identified by UniProt accession
Q9UBW5, 565 residues long.
MolForge cross-references it against 0 known binders and
116 disease associations.
Target properties
| Protein name | Bridging integrator 2 |
| UniProt accession | Q9UBW5 |
| Gene | BIN2 |
| Organism | Homo sapiens |
| Length | 565 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (116)
Diseases linked to this target (Open Targets).
- mean platelet volume · score 0.52
- cancer · score 0.46
- basophil count · score 0.40
- platelet count · score 0.40
- basophil percentage of leukocytes · score 0.30
- neutrophil count · score 0.24
- lymphocyte count · score 0.18
- inflammatory bowel disease · score 0.16
- platelet component distribution width · score 0.15
- myeloid white cell count · score 0.14
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9UBW5-F1 | alphafold | PREDICTED | 64.56 | — |
Amino-acid sequence (565 residues)
MAEGKAGGAA GLFAKQVQKK FSRAQEKVLQ KLGKAVETKD ERFEQSASNF YQQQAEGHKL YKDLKNFLSA VKVMHESSKR VSETLQEIYS SEWDGHEELK AIVWNNDLLW EDYEEKLADQ AVRTMEIYVA QFSEIKERIA KRGRKLVDYD SARHHLEAVQ NAKKKDEAKT AKAEEEFNKA QTVFEDLNQE LLEELPILYN SRIGCYVTIF QNISNLRDVF YREMSKLNHN LYEVMSKLEK QHSNKVFVVK GLSSSSRRSL VISPPVRTAT VSSPLTSPTS PSTLSLKSES ESVSATEDLA PDAAQGEDNS EIKELLEEEE IEKEGSEASS SEEDEPLPAC NGPAQAQPSP TTERAKSQEE VLPSSTTPSP GGALSPSGQP SSSATEVVLR TRTASEGSEQ PKKRASIQRT SAPPSRPPPP RATASPRPSS GNIPSSPTAS GGGSPTSPRA SLGTGTASPR TSLEVSPNPE PPEKPVRTPE AKENENIHNQ NPEELCTSPT LMTSQVASEP GEAKKMEDKE KDNKLISANS SEGQDQLQVS MVPENNNLTA PEPQEEVSTS ENPQL
Explore Bridging integrator 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets